Adam Schayowitz is an accomplished professional in the oncology and pharmaceutical sectors, currently serving as Operating Partner at EcoR1 Capital, LLC since September 2024. Adam has extensive experience, including membership on the Board of Prostate Cancer Research since 2021 and various leadership roles at Pfizer from 2018 to 2024, where responsibilities included heading product development teams and overseeing global clinical development for significant cancer treatments. Adam has also held advisory positions at multiple pharmaceutical companies, including Carrick Therapeutics and Zentalis Pharmaceuticals. Academic credentials include an MBA from The Johns Hopkins University - Carey Business School, a PhD in Pharmacology from the University of Maryland School of Medicine, and a BA in Neuroscience from Hamilton College.
This person is not in any teams
This person is not in any offices